Reinforcement Learning, an artificial intelligence approach, has the potential to guide physicians in designing sequential treatment strategies for better patient outcomes but requires significant improvements before it can be applied in clinical settings.
Turning aquatic vegetation near agricultural land into compost simultaneously eradicates habitat for disease-carrying snails while improving agricultural output and increasing incomes in northern Senegal, Cornell researchers have found.
Cornell researchers built miniature VR headsets to immerse mice more deeply in virtual environments that can help reveal the neural activity that informs spatial navigation and memory function and generate new insights into disorders such as Alzheimer’s disease and its potential treatments.
Prostate cancer hijacks the normal prostate’s growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers.
A newer hepatitis B vaccine was superior to an older type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to a study led by a Weill Cornell Medicine investigator.
Weill Cornell Medicine has received a four-year, $1.4 million grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.
A new app developed by Cornell computer science researchers helps users record highly accurate time-lapse videos of body parts – a surprisingly difficult task and an unmet need in remote medicine and telehealth applications.
An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.
